삼성바이오로직스
1,391,000KRWMarket close of 10/20 (Tue)
Down -2.52%-36,000KRWMarket close of 10/20 (Tue)
Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)1,417,000KRWUp +1.87%
Preliminary · just after the close · replaced by official KRX data tomorrow morning
- Open
- 1,420,000
- High
- 1,440,000
- Low
- 1,370,000
- Day range
- Day range low 1,370,000 high 1,440,000, open 1,420,000, close 1,391,000, previous close 1,427,000
- Volume
- 9×10K shares
- 129.9B KRW 1.55× the 20-session average
Market close of 10/20 (Tue)
Where it sits in the 1-year range
27%1-year close range 1,182,000 to 1,965,000 won, 27% up from the low
27% of the way up from the lowest close in 1 year (219 sessions) · -29.2% from the high
Usual range
Nothing unusual in the 6 checked items
Free · no sign-inSource from 2021-05-17
Points to check
- Daily moveusual range-2.52%-2.52%, 1.0× the usual (20-session average ±2.41%)That day -2.52% · usual ±2.41% · large-move threshold ±4.8%
- Trading valueusual range1.6×129.9B KRW, 1.6× the 20-session average1.55× the 20-session average · check threshold 3×
- Earningsusual range2.27 trillion KRWOperating income over the last four quarters 2.27 trillion KRW
The other 3 are within the usual range
- Recent filings0Last 14 days
- Foreign & institutional+144.0B KRWusual range
- Data date10/20 (Tue)Market close
See the full check report
Same sector · 제약
Down -1.68%· 29 of 168 stocks up, preferred shares excluded · trading value 827.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 셀트리온 | Close over the last 20 sessions +11.4% | Down -0.40% | 139.2B KRW |
| 삼익제약 | Close over the last 20 sessions -20.4% | Up +2.77% | 76.0B KRW |
| 녹십자엠에스 | Close over the last 20 sessions +30.5% | Up +6.67% | 55.6B KRW |
| 유한양행 | Close over the last 20 sessions +11.5% | Down -1.37% | 41.6B KRW |
| 현대약품 | Close over the last 20 sessions -23.7% | Up +3.68% | 31.9B KRW |
Schedule
- Q3 report due · 11/16 (Mon) · in 25 days
- Next data 10/22 (Thu) after 08:50
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.